death from semaglutide Kaplan-Meier curves based on eligibility created by Effectiveness of semaglutide on survival

Objectives Although GLP-1 receptor agonists appear to be efficacious in treating AD, there is not yet enough clinical evidence to support this claim

Butler PC, Elashoff M, Elashoff R, et al

They work by reducing appetite and helping you feel full, making it easier to stick to healthy eating habits

One honest caveat before going further

Because its mechanism goes beyond GLP-1 activation, patients who plateau or respond poorly to semaglutide or tirzepatide may achieve substantially greater results with retatrutide

While this system can identify adverse events associated with drug use, it cannot prove that these events are caused solely by the medication itself, nor can it exclude the potential influence of other underlying factors or concomitant drug use on the occurrence of adverse events